The [M] Factor Dallas Premiere Screening with Live Panel Discussion
Wednesday, November 13, 2024
6:15 PM - 8:30 PM
Violet Crown Theatre
3699 McKinney Avenue, Suite 100
Dallas, TX 75204
PROGRAM
6:15 PM | Doors Open and Reception
7:00 PM | Screening
(Film Length: 56:46 minutes)
8:00 PM | Live Panel Discussion
Legal Disclaimer:
No recording permitted of The [M] Factor Film screening via Zoom, cell phone capture, or any camera recording devices.
ABOUT THE FILM
“The [M] Factor: Shredding the Silence on Menopause” is a groundbreaking documentary that will empower and educate the 1.1 billion women worldwide who will be in menopause by 2025.
Menopause is a silent epidemic that affects millions of American women, resulting in billions in lost wages, upended careers, family disruptions, and emotional chaos. The film confronts the neglected menopause crisis, challenging societal and medical shortcomings and advocating for a revolutionary approach to women's health in America, where she’s prepared for midlife.
This film explores the hidden impact of menopause on women's lives. With evidence-based information, the film empowers women to make informed health decisions and aims to remove the stigma surrounding menopause and aging.
Meet the Panelists
-
Dr. Cheryl Cox Kinney, FACOG, MSCP
PANELIST
Dr. Kinney is a board-certified gynecologist and highly respected expert in the field of female health, menopause and vulvar disorders. She completed her residency at Indiana University and relocated to Dallas where she maintains her busy solo-practitioner office on the Medical City Hospital campus. Dr. Kinney is a Menopause Society Certified Practitioner, is the 2025 President-Elect of The Menopause Society and holds positions on various committees for other national women’s health organizations (ISSVD, ISSWSH).
Dr. Kinney is supported by a small team of nurses and administrative staff, all of whom have stayed with her since the inception of her private practice. This close-knit group works as an attentive team, dedicated to the well-being of her patients. Her nursing staff (all RNs) have extensive backgrounds in gynecology and female hormone disorders. Their broad clinical experiences are a valuable part of the care provided to her patients.
And, with three grown daughters of her own, Dr. Kinney has a wealth of knowledge, empathy and advice when addressing real-world women’s health issues. She has been happily married to her husband Craig for many years and they, together with their daughters, have traveled to some far-flung parts of the globe…. but they are all just as happy being at home with a good book!
-
Dr. Kamilia Smith, FACOG, MSCP
PANELIST
With over two decades dedicated to championing female well-being, Dr. Kamilia Smith pours her passion into advocating for women's health. Beyond her 20+ years in female health, she is a relentless supporter of granting women the time and attention they deserve, extending far beyond the childbearing years. In 2019, she established The Charleston House, a Dallas-based concierge gynecology practice, driven by her unwavering belief in a personalized and comprehensive approach to women’s healthcare and wellness. In 2023, she launched a new program, Charleston House Too, that is dedicated to helping students during the pivotal years between high school to college and early adulthood.
Dr. Smith's commitment extends across all stages of a woman's life, delving into intricate aspects of well-being, including mental health, sleep, stress management, sexual dysfunction, obesity, and hormone balance. Her mission transcends conventional healthcare, as she passionately advocates for an evolved model that resonates with the demands of the modern woman. Driven by determination, she strives to discover innovative solutions, aiming to elevate and refine the care provided to women.
Dr. Smith is Board Certified in Obstetrics and Gynecology and is a certified menopausal practitioner through the North American Menopause Society. Dr. Smith completed her medical degree at the University of Texas Health Science Center in San Antonio in 2003 and residency at Baylor University Medical Center in 2007. She has completed an Executive Healthcare Leadership Fellowship from Creighton University. Dr. Smith has also pursued additional training in obesity/weight management, sexual function and lifestyle medicine to address the many needs of today’s women.
-
Dr. Lyndsey Harper, FACOG, IF
PANELIST
Dr. Lyndsey Harper is a Board-Certified Ob/Gyn, Associate Professor of Ob/Gyn for Texas A&M College of Medicine, a Fellow of The American Congress of Obstetricians and Gynecologists, and a Fellow of the International Society for the Study of Women's Sexual Health.
Dr. Harper is the founder and CEO of Rosy, an award-winning women’s health technology company that connects women who have health concerns with hope, community, and research-backed solutions. She has been named Forbes Top 53 Women Disrupting Healthcare, People Newspapers’ 20 Under 40, a Top Innovator in North Texas, and a DBJ Top Woman in Tech.
-
Stephanie Collins
MODERATOR
Stephanie Collins, Founder and Chief Patient Advocate Officer of Eido Bio is a pioneering force in the biopharma industry with over 30 years of experience focused on rare diseases and innovative therapies. Her unique background blends nursing expertise with strategic business acumen, driving a patient-centered approach to drug development and commercialization.
Based in Dallas, Texas, Stephanie has led the launch of transformative therapies and spearheaded national disease awareness campaigns. Her work spans complex commercial strategies and team development, significantly impacting pharmaceuticals and biotech.
A respected mentor and industry leader, Stephanie is active in organizations like Professional Patient Advocates in Life Sciences, Healthcare Businesswomen's Association, and Women in Bio. Her strategic foresight and integration of nursing principles into business development have set new benchmarks in patient care and healthcare innovation.
Stephanie's career exemplifies a commitment to enhancing patient outcomes while navigating the biopharma sector's challenges, making her a transformative figure in the industry.
Helpful Information
-
-
Hormone Therapy has become most commonly known or referred to as Hormone Replacement Therapy (HRT). This is a bit of a misnomer, because the goal is not to replace the levels of hormones that once existed. The goal is to treat with the lowest amount of hormone that is effective for the person. Thus, making Hormone Therapy (HT) a more accurate term.
-
Doctors are not the authority of your body and health. You are. The most important things you can do is educate yourself and advocate for yourself.
Share with them your communication and learning style. Tell them what you need to be able understand the conversation. Here are some suggestions:
“Please talk slowly”
“I do best with pictures and metaphors”
Please be patient, I ask lots of questions”
Gather and summarize health and family history. Break it down by condition/health concern (e.g. thyroid, digestion, blood pressure etc.). Summarize onset, experience, what you have tried to address, what has seemed to work/not work. Prioritize what feels most important to you.
Gather labs and blood work and map them over time.
Enlist them in your integrative approach. Share other modalities you are employing or considering (e.g. acupuncture, homeopathy, cranio sacral, etc.). If they are resistant or dismissive, ask them about their level of experience and understanding of the modality and why they are not open to it.
Write down your questions in advance.
Avoid citing information you have seen on social media (even if from reputable sources). Instead, reference books, podcasts, studies, and evidenced-based guidelines.
Bring reference and guidelines with you.
Record the visit on your phone and transcribe later. Take written notes.
Some guidelines to reference:
2022 Clinical Practice Guidelines for the Use of Testosterone in Women
Global Consensus Position Statement on the use of Testosterone Therapy for Women
Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer
2024 Vaginal Estrogen Safety for Genitourinary Syndrome of Menopause in Breast Cancer Survivors
-
PEOPLE IMPACTED
More than 2 million women in the US enter menopause each year
1.1 Billion women will be in menopause by 2025
Each year 250,000 women in the U.S. experience premature menopause, whether naturally or surgically induced. (The Menopause Society)
Two-thirds of Alzheimer’s patients are women (Alzheimer’s Association)
TREATMENT
The Menopause Supplement Market is Forecast to reach more than $735 Million in 2025 (Nutrition Business Journal)
Prior to the 2002 WHI Study 40% of women used Hormone Therapy. After the 2002 WH Study, the number of women using Hormone Therapy dropped to 4% (The Menopause Society)
Testosterone is not FDA approved for women in the United States (it is for men and trans men).
SYMPTOMS
Menopause symptoms last (SWAN): 4.8 years for Japanese American women / 5.4 years for Chinese American women / 6.5 years for White women / 8.9 years for Latinas / 10.1 years for Black women
Latinos make up 17% of the US Population (UnidosUS)
43% of Latinas suffer from Heart Disease, almost 41% have high blood pressure (American Heart Association)
Up to 50% of Women experience painful sex and reduced libido during menopause. (The Menopause Society)
30% of women in menopause will lose a tooth in the first 5 years of menopause (Chief Dental Officer, Delta Dental of Oregon/Alaska)
EMPLOYMENT / ECONOMIC
Women over 50 are one of the fastest growing employment groups in the US (National Institutes of Health)
Women Lose $1.8 Billion in productivity ANNUALLY due to menopause symptoms
In 2023 only 4% of major U.S. Companies offered menopause benefits (Bloomberg)
EDUCATION / RESEARCH / FUNDING
In a nationwide survey of medical residency programs, only 31% reported having menopause curriculum (Augusta University Report)
Menopause Medicine, as subspecialty of OBGYN, requires highly skilled practitioners (The Menopause Society)
In 2022 the National Institute of Health $46 Billion, 10% went to women’s health
Executive order from president $12 Billion Allocated to Women’s Midlife Research